Utibron Neohaler Interactions
There are 602 drugs known to interact with Utibron Neohaler (glycopyrrolate/indacaterol), along with 19 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 22 are major, 486 are moderate, and 94 are minor.
- View all 602 medications that may interact with Utibron Neohaler
- View Utibron Neohaler alcohol/food interactions (4)
- View Utibron Neohaler disease interactions (19)
Most frequently checked interactions
View interaction reports for Utibron Neohaler (glycopyrrolate / indacaterol) and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- AirDuo Respiclick (fluticasone / salmeterol)
- albuterol
- Alvesco (ciclesonide)
- Anoro Ellipta (umeclidinium / vilanterol)
- Arcapta (indacaterol)
- Asmanex HFA (mometasone)
- Asmanex Twisthaler (mometasone)
- Bevespi Aerosphere (formoterol / glycopyrrolate)
- Breo Ellipta (fluticasone / vilanterol)
- Claritin (loratadine)
- Dulera (formoterol / mometasone)
- Fasenra (benralizumab)
- Flovent Diskus (fluticasone)
- fluticasone nasal
- Incruse Ellipta (umeclidinium)
- montelukast
- omeprazole
- ProAir HFA (albuterol)
- ProAir RespiClick (albuterol)
- Pulmicort Flexhaler (budesonide)
- Qvar RediHaler (beclomethasone)
- Seebri Neohaler (glycopyrrolate)
- Spiriva (tiotropium)
- Spiriva Respimat (tiotropium)
- Stiolto Respimat (olodaterol / tiotropium)
- Striverdi Respimat (olodaterol)
- Symbicort (budesonide / formoterol)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Tylenol (acetaminophen)
Utibron Neohaler alcohol/food interactions
There are 4 alcohol/food interactions with Utibron Neohaler (glycopyrrolate / indacaterol).
Utibron Neohaler disease interactions
There are 19 disease interactions with Utibron Neohaler (glycopyrrolate / indacaterol) which include:
- arrhythmias
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- tardive dyskinesia
- infectious diarrhea
- myasthenia gravis
- ulcerative colitis
- psychoses
- cardiovascular
- diabetes
- hypokalemia
- seizures
- Down's syndrome
- liver impairment
- renal impairment
- hypertension
- fever
More about Utibron Neohaler (glycopyrrolate / indacaterol)
- Utibron Neohaler consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bronchodilator combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.